- Home
- GOSS vs ELVR Comparison
GOSS vs ELVR Comparison
Compare GOSS & ELVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GOSS | ELVR |
|---|---|---|
| Founded | 2015 | 2000 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Mining & Quarrying of Nonmetallic Minerals (No Fuels) |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 796.2M | 890.2M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | GOSS | ELVR |
|---|---|---|
| Price | $2.89 | $52.48 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $8.60 | N/A |
| AVG Volume (30 Days) | ★ 4.4M | 79.4K |
| Earning Date | 11-05-2025 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $44,051,000.00 | ★ $146,440,045.00 |
| Revenue This Year | N/A | $22.93 |
| Revenue Next Year | $6.41 | $7.27 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 11.20 |
| 52 Week Low | $0.76 | $15.55 |
| 52 Week High | $3.87 | $54.95 |
Technical Indicators
Market Signals| Indicator | GOSS | ELVR |
|---|---|---|
| Relative Strength Index (RSI) | 39.59 | N/A |
| Support Level | $3.04 | N/A |
| Resistance Level | $3.87 | N/A |
| Average True Range (ATR) | 0.29 | 0.00 |
| MACD | -0.10 | 0.00 |
| Stochastic Oscillator | 1.49 | 0.00 |
Price Performance
Historical ComparisonAbout GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About ELVR Sayona Mining Limited American Depository Shares
Elevra Lithium Ltd is a mineral exploration and development company. The principal activity of the company is the identification, acquisition, and evaluation of mineral exploration assets, focusing on lithium. The projects of the company include the Moblan Lithium Project, the Carolina Lithium Project, the Ewoyaa Lithium Project, North American Lithium, and other projects. The company also holds an interest in a tenement portfolio in the Pilbara region, prospective for gold and lithium.